Boost Your Immunity: Powerful Mpox Vaccine Offers 58% Protection
The study estimates the real-world effectiveness of a single dose of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine in preventing mpox infection. Findings suggest that the vaccine provides moderate protection, with an effectiveness of 58%. The study emphasizes the importance of targeted vaccination in at-risk populations.